UK Drawing on a career spanning oncology drug discovery at AstraZeneca and biotech leadership as CEO of Enhanc3d Genomics, Hazel Jones is now Chief Strategy Officer at Laverock Therapeutics. We caught up with her at the Asia Summit on Global Health in Hong Kong, where the company was showcasing its programmable…
See our Cookie Privacy Policy Here
